In Brief
Restriction factors defend infected cells against viruses. Maelfait et al. find that SAMHD1, which blocks HIV-1 infection in myeloid cells, prevents innate sensing of infection via cGAS/STING. Furthermore, SAMHD1 curtails virus-specific T cell responses in vivo. Restriction by SAMHD1, therefore, limits subsequent innate and adaptive immune responses.
INTRODUCTION
Virus infection in mammalian hosts is controlled by a variety of mechanisms operating at different levels. These include cellintrinsic restriction systems, innate immune sensors that signal for the induction of an antiviral state, and cellular and adaptive immune responses. How these different branches of the antiviral response work together is important for successful immunity. The role of pattern-recognition receptors that sense infection for the development of subsequent immune responses has been well documented (Medzhitov, 2009 ). However, less is known about how virus control by restriction factors is linked with innate and adaptive immune responses.
Restriction factors have been studied in particular detail for HIV-1 and include APOBEC3G, TRIM5a, tetherin, and Mx2 (Rehwinkel, 2014; Simon et al., 2015) . Another HIV-1 restriction factor is SAMHD1, a deoxynucleoside triphosphate (dNTP) triphosphohydrolase that depletes the intracellular pool of dNTPs and thereby prevents HIV-1 reverse transcription in some cell types (Ayinde et al., 2012) . Additional mechanisms by which SAMHD1 might restrict infection have been proposed and include degradation and/or binding of viral nucleic acids (Ballana and Esté , 2015) .
Several studies suggested that SAMHD1-deficient cells produce elevated levels of type I interferons (IFNs) in response to HIV-1 infection. Indirect evidence for this idea stems from experiments using Vpx, a viral accessory protein encoded by HIV-2, but not HIV-1. Vpx targets SAMHD1 for proteasomal degradation (Hrecka et al., 2011; Laguette et al., 2011) . Depletion of SAMHD1 by Vpx in cultured human cells not only facilitates HIV-1 infection but also results in the induction of an antiviral response (Manel et al., 2010) . In addition, cells from patients with SAMHD1 mutations or cells in which SAMHD1 is depleted by RNAi produce more IFNs during HIV-1 infection (Berger et al., 2011; Puigdomè nech et al., 2013) . Subsequent work identified a role for cytosolic DNA sensing by cGAS and STING in IFN induction in Vpx-treated cells Lahaye et al., 2013) . Furthermore, SAMHD1 depletion in vitro in human dendritic cells (DCs) by Vpx delivery or RNAi enhances DC activation and antigen presentation upon HIV-1 infection and facilitates T cell responses in co-culture models (Ayinde et al., 2015) . However, the interpretation of these data is complicated by the possibility that Vpx targets additional proteins apart from SAMHD1 (Fujita et al., 2012; Reinhard et al., 2014) , by genetic heterogeneity of patients' cells, and by recent results that failed to reproduce enhanced DC activation in HIV-1-infected cells depleted of SAMHD1 (Hertoghs et al., 2015) . In vivo data and genetic studies in knockout models interrogating the possible role of SAMHD1 in innate and adaptive immune responses to HIV-1 are currently lacking.
Mutations in human SAMHD1 cause Aicardi-Goutiè res syndrome (AGS), a rare monogenic disorder resembling congenital virus infection and typified by early-onset brain disease (Rice et al., 2009) . AGS patients spontaneously produce IFNs in the absence of infection with exogenous viruses (Crow and Manel, 2015) . These observations suggest that SAMHD1 prevents the accumulation of endogenous nucleic acids that induce IFNs. Others and we previously reported spontaneous IFN production in Samhd1 À/À mice and cells, mimicking the situation in AGS patients (Behrendt et al., 2013; Rehwinkel et al., 2013) . The identity and source of the cellular IFN-stimulatory nucleic acid and the signaling pathway activated by it are important open questions (Roers et al., 2016) . We show that cGAS and STING mediate chronic IFN production in Samhd1 À/À mice and cells. We further show that SAMHD1-deficient myeloid cells produce heightened levels of IFNs in response to infection with VSV-G-pseudotyped HIV-1-derived lentiviruses and are activated more strongly. These effects required reverse transcription and were nullified in cells from Samhd1 À/À mice also lacking cGAS, STING, or IFNAR. We also demonstrate that the induction of antigen-specific T cell responses is limited by SAMHD1 in vivo. Therefore, virus control by SAMHD1 at the level of the infected cell limits innate and adaptive immunity.
RESULTS
The Spontaneous IFN Response in Samhd1 À/À Cells and Mice Requires cGAS and STING AGS is a prototypical interferonopathy, a group of diseases characterized by chronic and pathologic IFN production (Crow and Manel, 2015) . Mutation of SAMHD1 or one of at least six other genes, including TREX1 and RNASEH2A-C, causes AGS (Crow and Manel, 2015) . Others and we previously showed that Samhd1 À/À mice and cells display a spontaneous IFN signature, although SAMHD1-deficient animals do not develop autoimmunity (Behrendt et al., 2013; Rehwinkel et al., 2013) . Given that SAMHD1's enzymatic function is to degrade dNTPs, the building blocks of DNA, we hypothesized that cytosolic DNA sensing might account for IFN induction in the absence of SAMHD1.
To test this, we first cultured bone marrow-derived macrophages (BMDMs) from SAMHD1-cGAS (Mb21d1 À/À ) or SAMHD1-STING (Tmem173 À/À ) double-knockout mice. Consistent with previous observations, Samhd1 À/À BMDMs expressed higher mRNA levels of the interferon-stimulated genes (ISGs) Ifi44, Ifit1, and Ifit2 compared to wild-type cells ( Figure 1A ). However, the expression of these ISGs was not increased in cells lacking both SAMHD1 and STING or cGAS compared to single-knockout control cells ( Figure 1A ). It is noteworthy that basal ISG expression was reduced in cGAS-and STING-deficient cells. Wild-type BMDMs thus maintain basal expression of ISGs and this requires an intact cytosolic DNA-sensing pathway. ISG15 is an IFN-inducible ubiquitin-like protein modifier with antiviral functions (Morales and Lenschow, 2013) . Samhd1 amounts of high-molecular-weight proteins, which were covalently modified by ISG15 ( Figure 1B ). Enhanced ISGylation was not observed in SAMHD1-deficient BMDMs that did not express cGAS or STING ( Figure 1B) .
To confirm these findings in vivo, we analyzed spleens from 6-month-old Samhd1 À/À mice for the expression of several
ISGs. The mRNA levels of Ifi44, Ifit1, Oasl1, and Isg15 were significantly increased in Samhd1 À/À spleens ( Figure 1C ). However, the expression of these genes was reduced to wild-type levels when SAMHD1 was knocked out together with cGAS or STING ( Figure 1C ). In sum, these data show that SAMHD1 prevents spontaneous engagement of the cGAS/STING pathway.
SAMHD1 Limits IFN Induction and Myeloid Cell Activation upon Lentivirus Infection
Vpx-mediated degradation of SAMHD1 enables productive infection of human DCs and relieves a block to IFN induction and DC activation ( Figure S1 ) (Manel et al., 2010) . To test this in a genetically tractable system, we generated bone marrowderived myeloid cells (BMMCs) from wild-type and Samhd1
mice (Helft et al., 2015) . Others and we previously showed that SAMHD1 restricts infection of these cells with HIV-1-based lentiviruses (Behrendt et al., 2013; Rehwinkel et al., 2013) . Profound SAMHD1-dependent restriction both in vitro and in vivo was only observed when the pol gene carried a point mutation (V148I), which decreases the affinity of the viral RT for dNTPs (Rehwinkel et al., 2013) . Second-generation lentiviruses used in our previous study (SGLenti-RT   V148I ), which have a minimal genome encoding only EGFP ( Figure S2A ), were efficiently restricted by SAMHD1, but they did not induce BMMC activation or IFN secretion (Rehwinkel et al., 2013) .
We therefore infected murine BMMCs with first-generation lentiviruses (FGlenti) that induce IFN in human monocyte-derived dendritic cells (MDDCs) ( Figure S1 ). To allow for potent restriction by SAMHD1, we introduced the V148I point mutation into the pol gene of FGLenti ( Figure S2A ). Infection of BMMCs with both first-and second-generation lentiviruses was equally suppressed by SAMHD1 (Figures 2A and S2C ). However, only FGLenti-RT V148I induced cell surface expression of the co-stimulatory molecules CD40, CD80, and CD86 and secretion of IFNa and the chemokine CXCL10, and these effects were significantly elevated in SAMHD1-deficient cells ( Figures 2B, 2C , S2D, and S2E). Ifit1 and Ifi44 mRNA and ISG15 protein expression and conjugation were enhanced in SAMHD1-deficient BMMCs (Figures 2D and 2E) . Taken together, these data provide direct genetic evidence that SAMHD1-mediated restriction impedes detection of lentivirus infection in myeloid cells.
Viral cDNA Synthesis Is Required for Myeloid Cell Activation
To determine at which step in the viral life cycle HIV-1 is sensed in SAMHD1-deficient myeloid cells, we treated BMMCs with the RT inhibitor nevirapine or the integrase inhibitor raltegravir during infection with FGLenti-RT
V148I
. Both compounds inhibited infection ( Figure 3A ), but only inhibition of reverse transcription prevented BMMC activation and CXCL10 and IFNa production ( Figures 3B, 3C , S3A, and S3B). SAMHD1 may restrict HIV by multiple mechanisms, including by preventing cDNA synthesis and by degrading incoming viral genomic RNA. We found that HIV-1 cDNA accumulated over 24 hr at 10-fold higher levels in Samhd1 À/À BMMCs compared to wild-type cells ( Figure 3D ).
In contrast, viral RNA levels measured at 4 hr post-infection were not affected by SAMHD1 ( Figure 3E ). At this time point we observed higher induction of Ifnb and Ifit1 mRNAs in SAMHD1-deficient BMMCs ( Figure 3F ). These results indicate that viral RNAs do not trigger the IFN response at this time point, which instead depends on reverse transcription and correlates in magnitude with reverse transcription products. 4J , S4C, and S4D). In sum, these observations provide genetic evidence that cGAS, STING, and signaling through the type I IFN receptor are required for SAMHD1-dependent myeloid cell activation upon lentivirus infection.
SAMHD1 Reduces the Antiviral CD8 T Cell Response In Vivo
Given that SAMHD1 curtails the induction of IFN and the activation of myeloid cells in vitro, we tested whether SAMHD1 limits adaptive immune responses. We fused the OVA 257-264 peptide SIINFEKL, a model antigen for CD8 T cells (Carbone and Bevan, 1989) , to the C terminus of the matrix protein ( Figure S5A ). The resulting FGLenti-RT V148I SIINFEKL virus behaved identically to the parental virus in terms of virus production, gag processing, infectivity, and BMMC activation ( Figures S5B-S5F ). Furthermore, SIINFEKL presentation by H-2Kb was enhanced in Samhd1 À/À cells ( Figure 5A ).
Next we compared the antigen-specific CD8 T cell response in wild-type and Samhd1 À/À animals. Compared to wild-type mice, infection of Samhd1 À/À animals resulted in 4-and 10-fold increased tetramer-positive CD8 T cell populations in blood and spleens, respectively ( Figures 5B, 5C , and S5G). Spleens of Samhd1 À/À mice contained more CD8 T cells producing
IFNg upon SIINFEKL re-stimulation than those of wild-type controls ( Figures 5D and 5E ), but not after phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation ( Figure S5H ). SAMHD1-cGAS double-knockout mice mounted a similar antigen-specific CD8 T cell response compared to mice lacking only SAMHD1 ( Figure S5I ). This indicates that the increased antigen load in Samhd1 À/À animals determines the magnitude of the CD8 T cell response in this model. To exclude direct effects of SAMHD1 on the CD8 T cell repertoire or T cell activation, we injected Samhd1 À/À and wild-type mice with OVA protein using cGAMP as an adjuvant (Li et al., 2013) . This resulted in comparable SIINFEKL-specific CD8 T cell responses in wildtype and Samhd1 À/À mice ( Figures S5J and S5K) . We conclude that SAMHD1 limits lentivirus-specific T cell responses to lentiviral infection in vivo.
DISCUSSION
Our study provides genetic and in vivo data that the restriction factor SAMHD1 does not operate in conjunction with other innate and adaptive immune responses to ensure control of lentivirus infection. Instead, SAMHD1 limits the induction of IFNs, ISGs and co-stimulatory molecules as well as the amounts of antigen presented by infected myeloid cells in vitro. Furthermore, SAMHD1 limits the magnitude of the CD8 T cell response induced in vivo. Cell-autonomous virus restriction by SAMHD1, therefore, competes with sensors of infection and T cell responses. This antagonistic relationship between SAMHD1 and innate and adaptive immune responses is of importance for our understanding of lentiviral pathogenicity, and it may provide therapeutic opportunities to control viral infections. It is interesting to ask whether this concept also applies to other restriction factors. Indeed, a recent study showed that cultured DCs inactivate TRIM5a's function by redirecting the protein to the cell nucleus, and it suggested that this reflects an evolutionary trade-off in DCs, in which restriction is minimized to allow for more efficient sensing (Portilho et al., 2016) . However, other restriction factors do not compete with but rather facilitate subsequent innate and adaptive immune responses. APOBEC3 is required for efficient production of antibodies in retrovirus-infected mice (Santiago et al., 2008 (Santiago et al., , 2010 Smith et al., 2011) , and human APOBEC3G facilitates T cell responses (Casartelli et al., 2010) . Tetherin promotes NK and CD8 T cell responses in a mouse model of retrovirus infection (Li et al., 2014) . Interestingly, some restriction factors, including TRIM5a and tetherin, also operate as sensors of infection and induce NF-kB (Galã o et al., 2012; Pertel et al., 2011) . Viral restriction factors thus differentially impact the host's immune responses, and it is likely that this complexity is due to host-pathogen coevolution.
A first hint at the possibility that SAMHD1 prevents sensing of virus infection came from its implication in AGS, a rare autoinflammatory disease characterized by chronic IFN production (Rice et al., 2009 (Rehwinkel et al., 2013) , these data suggest that an unusual endogenous DNA accumulates in SAMHD1-deficient cells and engages cGAS. This mirrors the situation in TREX1-and RNASEH2-deficient cells (Roers et al., 2016) . We further report that IFN production in lentivirus-infected Samhd1 À/À myeloid cells requires cGAS and STING. Induction of antiviral responses was dependent upon reverse transcription, implicating viral reverse-transcribed DNA as the cGAS trigger. These data provide genetic evidence that lentivirusinduced innate immune responses are dependent on cytosolic DNA sensing. As reported for human DCs (Manel et al., 2010) , we find that first-generation lentiviruses encoding a full genome and second-generation viruses with a minimal genome differ in their abilities to induce IFN. It has been suggested that newly expressed gag unmasks non-integrated cDNA in the DC cytosol, making it available for detection by cGAS (Lahaye et al., 2013; Manel et al., 2010) . Indeed, gag is expressed by first-generation lentiviruses, but not by second-generation viruses. Specific nucleic acid sequences or secondary structures only present in the full HIV-1 genome may also, perhaps in conjunction with additional host proteins, contribute to IFN induction (Herzner et al., 2015; Yoh et al., 2015) .
To study the impact of lentivirus restriction by SAMHD1 on cytotoxic T cell responses in an in vivo model, we generated a lentivirus expressing the OVA peptide SIINFEKL. We found that infected Samhd1 À/À myeloid cells better presented this model antigen. Enhanced antigen presentation also had been observed in HIV-1-infected human DCs upon SAMHD1 depletion with Vpx or RNAi, and these treatments resulted in stronger T cell responses in co-culture models (Ayinde et al., 2015; Manel et al., 2010) . These in vitro studies, however, mostly relied on HIV-1-specific memory T cells, which have altered requirements for activation (Berard and Tough, 2002) . It was, therefore, important to establish an in vivo model in which naive T cells are primed. Notably, we found that antigen-specific CD8 T cell responses were up to 10-fold stronger in Samhd1 À/À mice compared to wild-type controls upon infection with the SIINFEKL-encoding lentivirus. It is interesting to ask whether this is due to enhanced antigen levels and/or to augmented co-stimulation and secretion of cytokines by antigen-presenting cells. We found that the SIINFEKL-specific T cell response was similarly enhanced in infected Samhd1 À/À and Samhd1
; Mb21d1 À/À animals. Thus, in this setting, increased antigen levels are largely responsible for the effect of SAMHD1 on the T cell response. However, H-2Kb-bound SIINFEKL elicits strong T cell responses due to its exceptionally high affinity for the T cell receptor, and little signals 2 and 3 (co-stimulation and cytokines) are required for the SIINFEKL response (Denton et al., 2011) . It will therefore be interesting to test other antigens in the future. An interesting comparison can be made with HIV-2, which overcomes SAMHD1-mediated restriction by encoding the antagonist Vpx (Hrecka et al., 2011; Laguette et al., 2011) . In line with our conclusion that SAMHD1 limits immune responses, in vitro infection of DCs with HIV-2 results in potent IFN induction (Lahaye et al., 2013) . In humans, HIV-2 infection in comparison with HIV-1 infection is characterized by better immune control, and fewer HIV-2-infected individuals progress to disease (Nyamweya et al., 2013; Rowland-Jones and Whittle, 2007) . It is possible that these effects are due in part to relief of SAMHD1-mediated restriction in HIV-2-infected cells, allowing for better innate and adaptive immune responses, and that HIV-1 has become the more successful pathogen by allowing itself to be restricted by SAMHD1. Consistent with this notion are observations in HIV-1 elite controllers. The expression level of SAMHD1 is reduced in DCs from elite controllers; these cells mount enhanced IFN responses to infection and are superior in vitro in stimulating CD8 T cells (Martin-Gayo et al., 2015) .
These observations, together with the genetic evidence presented here for an inhibitory role of SAMHD1 on immune responses, suggest a strategy for the development of an efficient HIV-1 vaccine in the form of a replication-deficient virus that circumvents restriction by SAMHD1. These could be achieved either by inclusion of Vpx or by the development of small molecule inhibitors of SAMHD1. Pharmacological inhibition of SAMHD1 also could be useful in therapeutic approaches aimed at eradicating latent HIV-1. These strategies often rely on re-activation of latent provirus and subsequent killing of the virus by the immune system, which we predict would be more effective in the absence of SAMHD1 (Margolis and Hazuda, 2013) . In sum, our work sheds light on the in vivo interplay among different branches of the antiviral immune system, and these insights have important implications for controlling infection.
EXPERIMENTAL PROCEDURES Mice
All mice were on the C57Bl/6 background. Samhd1 À/À mice were described previously (Rehwinkel et al., 2013) . Ifnar1 À/À mice were a gift from C. Reis e Sousa and were originally described in (M€ uller et al., 1994) . Tmem173
À/À (STING-deficient) mice were a gift from J. Cambier (Jin et al., 2011) . Mb21d1 À/À (cGAS knockout first) mice were described in Bridgeman et al. (2015) . This work was performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and institutional guidelines for animal care. This work was approved by a project license granted by the UK Home Office (PPL No. 40/3583) and also was approved by the Institutional Animal Ethics Committee Review Board at the University of Oxford.
Virus Production, Infection, and OVA-cGAMP Immunizations All lentiviruses were produced in TLA HEK293T cells. Cells were transfected using Fugene6 (Promega) using the plasmid combinations listed in Table S2 . All viruses were VSV-G pseudotyped. Medium was replaced the day after transfection, and 48 hr later supernatant was collected and filtered through a 0.45-mm polyethersulfone (PES) filter. Virus was concentrated by centrifugation over a 20% sucrose cushion at 50,000 3 g for 2 hr. Viral titers were determined on TLA HEK293T cells by fluorescence-activated cell sorting (FACS) based on GFP expression. Target cells were infected in the presence of 8 mg/ml polybrene (Sigma-Aldrich). After 2 hr, the inoculum was washed away and replaced with fresh medium. For measuring viral cDNA and RNA, virus was incubated with 10 U/ml DNase I (Turbo DNase I, Thermo Fisher Scientific) for 30 min at 37 C in 13 reaction buffer diluted in RPMI. Then 10 mM nevirapine or raltegravir was added to the cells 30 min prior to infection. Mice were infected by intravenous injection of 100,000 IU of FGLenti-RT V148I SIINFEKL (see Figure S5G for virus titration). For immunization with OVA and cGAMP, mice were anesthetized with isoflurane and injected intramuscularly with 10 mg 2 0 3 0 -cGAMP (Biolog, C 161) and 10 mg endotoxin-free OVA (Hyglos, 321000).
In Vitro Peptide Restimulation Assay
Spleen cells (2 3 10 6 ) were stimulated with SIINFEKL peptide (InvivoGen, 10 À13 -10 À8 M). After 1 hr, 10 mg/ml brefeldin A (Sigma-Aldrich) was added to the cells, and 5 hr later, cells were collected for intracellular IFNg staining. Cells were stained for cell surface markers and intracellular molecules, and they were fixed and permeabilized in Cytofix/Cytoperm (BD Biosciences) according to the manufacturer's instructions.
Statistics
Statistical analysis was performed in GraphPad Prism v7.00 as detailed in the figure legends.
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